A5E-24544-87334
2 vaccinations
2 coded responses
20 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 130 / NY
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Moderna
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
- 2021-01-16
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: Metallic taste mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-22
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-12
Dose 2 — Moderna
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-18
- 2021-02-21
- 2021-03-05
- 2021-03-14
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-02-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-12 | Moderna |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Metallic taste mild
Release 11 — 12 months, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release